OsteoCentric Technologies has entered into a non-exclusive licensing agreement with Globus Medical.
OsteoCentric’s MIS Bone Preservation Tapping Technology & Instant Interlocking Thread-form is the first implant-to-bone interface capable of sustaining primary implant stability over time, according to a March 11 news release.
The company has technology across orthopedic market segments including total joint reconstruction, trauma, spine, joint fusion and sports medicine.
